Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
ACQUISITION OF ARGATROBAN BUSINESS IN EUROPE
Contributed by:
PR Newswire
Images
Tags
Ethypharm-Acq
More Like This
Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries
Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome
